Georgetown University

Washington D.C., District of Columbia 20057-1168

35 studies enrolling now · 266 studies all time

What they study most

1st Line NSCLC, AIDS, Acquired Hemophilia A, Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Myeloid Leukemia, Adenocarcinoma, Adenocarcinoma of Prostate, Adolescent Behavior, Advanced Breast Cancer, Advanced Cancer, Advanced Lung Cancer, Advanced Lung Carcinoma

Studies at this site

• Pridopidine Phase 3 Study in Huntington's Disease — Recruiting now
• Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors — Recruiting now
• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — Recruiting now
• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
• A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) — Recruiting now
• A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma — Recruiting now
• ASSESS ALL ALS Study — Recruiting now
• PREVENT ALL ALS Study — Recruiting now
• A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease — Recruiting now
• Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis — Recruiting now
• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now
• Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer — Recruiting now
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders — Recruiting now
• Does Social Media Impact Adolescent Mental Health? — Recruiting now
• A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies — Recruiting now
• A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery — Recruiting now
• Gilteritinib for the Treatment of ALK NSCLC — Recruiting now
• Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery — Recruiting now
• Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis — Recruiting now
• Bundled Cancer Screening and Genetic Services Navigation — Recruiting now
• HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease — Recruiting now
• Clinical Trial of Approaches to Prostate Cancer Surgery — Recruiting now
• Lupus Landmark Study: A Prospective Registry and Biorepository — Recruiting now
• Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer — Recruiting now
• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• The DC Cohort Longitudinal HIV Status Neutral Study — Recruiting now
• Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients — Recruiting now
• Omega-3D: Omega-3 for Diet-Driven Health Disparities — Recruiting now
• Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC — Recruiting now
• The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI — Recruiting now
• Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration — Recruiting now
• Older Breast Cancer Patients: Risk for Cognitive Decline — Recruiting now
• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis — Running, not enrolling
• Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial — Running, not enrolling
• TheraSphere With Durvalumab and Tremelimumab for HCC — Running, not enrolling
• Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV — Completed
• Longitudinal Early-onset Alzheimer's Disease Study Protocol — Running, not enrolling
• Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) — Running, not enrolling
• HEALEY ALS Platform Trial - Master Protocol — Running, not enrolling
• The BD Liverty™ TIPS Stent Graft Study — Running, not enrolling
• Seroprevalence of Hepatitis E in People With an Organ Transplant — Completed
• Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) — Running, not enrolling
• Alzheimer's Disease Neuroimaging Initiative 4 — Enrolling by invitation
• Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A — Running, not enrolling
• Human Epilepsy Project 3 — Completed
• BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B — Stopped early